They found that a small percentage of cases remained, and these were categorized under AML M3 as per FAB classification, which is now categorized as acute promyelocytic leukemia (APL) with PML/RARA under AML-RGA (8,14,15). The gene discussed is RARA; the disease is acute myeloid leukemia.